8.12 am | 07 Feb 2012 |  Source: Moneycontrol.com

Looks like spring’s already here for the markets! Indian bourses ended a volatile session on a high yesterday. The Nifty gained 35 points while the Se...

1.18 pm | 31 Jan 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Praful Borah of Nirmal Bang Institutional Equities speak about Glenmark, Divi's results and gives his outlook going forw...

10.27 am | 31 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics is of the view that one can buy Ranbaxy for day trading....

9.59 am | 31 Jan 2012 |  Source: CNBC-TV18

Profit booking after a stellar performance in the last four weeks, has Sudarshan Sukhani of s2analytics telling CNBC-TV18’s viewers that today is one ...

4.53 pm | 30 Jan 2012 |  Source: Moneycontrol.com

PINC Research is bearish on Ranbaxy Laboratories and has recommended sell rating on the stock with a target price of Rs 355 in its January 27, 2012 re...

6.26 pm | 27 Jan 2012 |  Source: CNBC-TV18

Ranbaxy was a stock that cracked in trade today as details of the consent decree by US Justice Department were made public and turned out more stringe...

5.08 pm | 27 Jan 2012 |  Source: CNBC-TV18

PN Vijay, Portfolio Manager, www.askpnvijay.com shares his view on BHEL and Ranbaxy Labs....

12.51 pm | 27 Jan 2012 |  Source: Moneycontrol.com

PINC Research bearish on Ranbaxy Labs and has recommended sell rating on the stock with a target of Rs 355 in its January 27, 2012 research report....

9.18 am | 27 Jan 2012 |  Source: Moneycontrol.com

Ranbaxy has announced court filing of consent decree with US FDA. The company has agreed to make broad changes at its plants in US and India as part o...

9.16 am | 27 Jan 2012 |  Source: CNBC-TV18

Time to book profits and exit positions, says Ambareesh Baliga of Way2wealth, adding that buyers at these levels will be caught on the wrong foot....

9.12 am | 27 Jan 2012 |  Source: CNBC-TV18

Buy Ranbaxy at lower levels with trading perspective, says Ambareesh Baliga of Way2wealth....

8.30 am | 27 Jan 2012 |  Source: Moneycontrol.com

Global markets cheered the Fed's decision to hold interest rates at 'exceptionally low levels' for at least two years hinting at further economic stim...

8.16 am | 27 Jan 2012 |  Source: CNBC-TV18

NMDC | Kirloskar Oil | Tata Steel | MSP Steel | Central Bank of India | Triveni Engineering | Infosys | Ranbaxy and BHEL are stocks, which are in the ...

9.26 am | 26 Jan 2012 |  Source: PTI

In an unprecedented move, the US Justice Department has sought a permanent injunction against Ranbaxy, a move that will require the Indian pharmaceuti...

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

6.20 pm | 11 Jan 2012 |  Source: Moneycontrol.com

KRChoksey has come with its December quarterly earning estimates for Pharma sector. According to the research firm, Q3FY12 is expected to be a strong ...

11.19 am | 11 Jan 2012 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

12.32 pm | 21 Dec 2011 |  Source: Moneycontrol.com

PINC Research is bearish on Ranbaxy Laboratories and has recommended reduce rating on the stock with a target price of Rs 355 in its December 21, 2011...

2.50 pm | 07 Dec 2011 |  Source: Moneycontrol.com

Emkay Global Financial Services is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target price of Rs 513 in...

10.32 pm | 02 Dec 2011 |  Source: CNBC-TV18

After a sluggish first quarter, pharma universe reported some encouraging numbers in the second quarter. This is with some support from stable growth ...